NCT03158857View on ClinicalTrials.gov

Hepatitis C Treatment Study in Myanmar

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

January 31, 2022

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
Hepatitis C
Interventions
DRUG

Sofosbuvir 400 mg

These drugs are being offered as part of routine care

Trial Locations (1)

Unknown

Medical Action Myanmar, Yangon

Sponsors

Collaborators (1)

Medical Action Myanmar
All Listed Sponsors
collaborator

Myanmar Liver Foundation

OTHER

collaborator

Medical Action Myanmar

OTHER

lead

Myanmar Oxford Clinical Research Unit

OTHER

NCT03158857 - Hepatitis C Treatment Study in Myanmar | Biotech Hunter | Biotech Hunter